Health·2,850 stories
Cambridge scientists have built linked brain‑spinal‑cord organoids that reveal a developmental gene network limiting axon regeneration and show that blocking this switch, especially with the hormone d
A new study shows that inhaled CBD dampens neuroinflammation in Alzheimer’s mouse models, highlighting chronic brain inflammation as a core disease driver. The findings broaden therapeutic focus beyon
Longtime biotech executive Jeremy Levin warns that the institutions underpinning the US biotech industry — from regulators and investors to public trust in science — are fracturing even as scientific
A new study shows that mosquitoes can learn to associate the repellent DEET with a blood meal, making the scent attractive after feeding. Researchers observed up to 60% of trained insects attempting t
A new STAT+ Pharmalittle briefing reveals that President Trump’s most‑favored‑nation drug deals will finally expose U.S. drug prices, with three upcoming launches—Baxfendy, Awiqli, and Veppanu—set to
As the ASCO conference in Chicago prepares to spotlight pancreatic cancer, the biotech sector is abuzz with breakthroughs—from engineered heart patches to GSK’s hepatitis‑B functional cure—while new d
The UK National Screening Committee has advised the government to reject nationwide prostate‑specific antigen testing, deeming it more harmful than beneficial, while endorsing limited biennial screeni
Researchers from Occidental College and UC Irvine have developed an experimental, non-invasive vision correction technique called electromechanical reshaping (EMR) that uses mild electrical pulses and
3D-printed lymph node-like structures could revolutionize CAR T-cell therapy by slashing production time and cost, addressing a major barrier in global access. Researchers in Barcelona found their bio
The FDA’s early‑January guidance, a concrete step in the Trump administration’s deregulation drive, now lets wellness wearables estimate blood pressure and glucose without pre‑market approval. Compani
The UK’s National Screening Committee concluded that routine PSA testing for prostate cancer does more harm than good for most men, recommending it only for a few thousand high‑risk individuals carryi
The American Society of Clinical Oncology’s annual meeting begins in Chicago on June 1, 2026, drawing the oncology community for a packed exhibition. The marquee highlight is Revolution Medicines’ Pha
Polygenic risk scores are rapidly entering personalized medicine, but U.S. anti‑discrimination statutes lag behind. While GINA and the ADA shield workers from firing based on genetic data, they do not
GSK’s experimental drug bepirovirsen achieved functional cure in about one‑fifth of chronic hepatitis B patients in two Phase 3 trials, dwarfing the 1‑3% cure rates of existing nucleoside‑analogue the
While SKIMNEWS has been tracking the US‑Iran standoff, Meta’s AI rollout on Threads, and Strategy’s debt retirement, a new University of Pennsylvania study spotlights a potential disease‑modifying bre
A Finnish brain‑imaging study of 14 long‑COVID patients finds no widespread neuroinflammation, but reveals heightened activity in mood‑related brain regions. The results challenge the prevailing infla
A small University of Bristol‑led trial found that tocilizumab, an IL‑6 blocking drug used for rheumatoid arthritis, eased symptoms in patients with treatment‑resistant depression and low‑grade inflam
Researchers have identified a previously unknown gut-brain signaling network — built around the peptide CNMa — that detects protein deficiency and reprograms cravings to favor essential amino acids ov
Physicists at the Collège de France have drafted the first full quantum version of a pendulum clock, using a single atom, two mirrors and photons to create an autonomous ticking mechanism. The design
NASA selected Blue Origin over SpaceX to conduct the first of three uncrewed 2026 lunar missions aimed at building a $20bn moon base, with Administrator Jared Isaacman pitching an "iterative approach"
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.